PharmaDispatch is a paid subscription service.
Subscription options are available for individuals, small and large companies.
Individual subscriptions can be arranged for an annual fee of AUD$499 (plus GST).
PharmaDispatch offers a limited free trial. Email (email@example.com) for more information.
Subscriptions include immediate access to all website content, including daily news updates, opinion and analysis. It also entitles subscribers to re-purpose a PharmaDispatch analysis, such as for use in their own strategic or operational plans.
We have designed packages with wider use in mind. PharmaDispatch offers corporate packages starting with 5 user licenses. We will negotiate with individual organisations for tailored packages that include over 100 user licenses, or individual and confidential projects.
Subscriptions can be arranged directly at firstname.lastname@example.org or by calling 0408 492 937.
More cases are probably comingJuly 24, 2017 - Latest News
Supply chain delivered on HCVJuly 24, 2017 - Latest News
Americans want action to protect innovationJuly 24, 2017 - Latest News
Need to keep pace with more active consumerJuly 24, 2017 - Latest News
MSD and Pfizer back Trump innovation planJuly 24, 2017 - Latest News
Another senior official leaves pharmaceutical benefitsJuly 21, 2017 - Latest News
TPP11 discussions continueJuly 21, 2017 - Latest News